Article Information
History
- February 10, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Cameron Shand, PhD1,
- Pawel J. Markiewicz, PhD2,
- David M. Cash, PhD3,
- Daniel C. Alexander, PhD1,
- Michael C. Donohue, PhD4,
- Frederik Barkhof, MD2,5,
- Neil P. Oxtoby, PhD1,*,
- the Alzheimer’s Disease Neuroimaging Initiative
- 1Centre for Medical Image Computing, Department of Computer Science, University College London, London, UK
- 2Centre for Medical Image Computing, Department of Medical Physics and Biomedical Engineering, University College London, London, UK
- 3Dementia Research Centre, UCL Queen Square Institute of Neurology, University College London, London, UK
- 4Alzheimer’s Therapeutic Research Institute, Keck School of Medicine, University of Southern California, San Diego, USA
- 5Department of Radiology and Nuclear Medicine, VU University Medical Center, Amsterdam, Netherlands
- ↵*Corresponding author: Neil Oxtoby, email: n.oxtoby{at}ucl.ac.uk
Posted February 10, 2023.
Heterogeneity in Preclinical Alzheimer’s Disease Trial Cohort Identified by Image-based Data-Driven Disease Progression Modelling
